Intervention not reported
Proportion of patients who discontinued treatment due to adverse events (28 weeks trial period) · Patients between five and 15 years old with a diagnosis of BECTS
The intervention showed no clear difference in proportion of patients who discontinued treatment due to adverse… (low certainty).
1 finding from 1 review
Intervention not reported
Proportion of patients with an adverse event: · Patients between five and 15 years old with a diagnosis of BECTS
1 finding from 1 review
Intervention not reported
Proportion of patients with a particular or serious adverse event: 1. Somnolence 2. Rash · Patients between five and 15 years old with a diagnosis of BECTS
1 finding from 1 review
Intervention not reported
Changes in cognitive function testing from baseline (28 weeks trial period) · Patients between five and 15 years old with a diagnosis of BECTS
1 finding from 1 review
Intervention not reported
Proportion of patients who are seizure free at 3 months · Patients between three and 10 years old with a diagnosis of BECTS
The intervention probably leads to higher proportion of patients who are seizure free at 3 months (moderate certainty).
1 finding from 1 review
Intervention not reported
Proportion of patients who are seizure free at 6 months · Patients between three and 10 years old with a diagnosis of BECTS
The intervention probably leads to higher proportion of patients who are seizure free at 6 months (moderate certainty).
1 finding from 1 review
Intervention not reported
Time to first seizure after randomisation · Patients between three and 10 years old with a diagnosis of BECTS
The intervention probably leads to higher time to first seizure after randomisation (moderate certainty).
1 finding from 1 review
Intervention not reported
Proportion of patients who had seizure remission in the last 9 months of the study · Patients with a clinical and EEG diagnosis of BECTS
It is very uncertain whether the intervention changes proportion of patients who had seizure remission in the last 9… (very low certainty).
1 finding from 1 review
Intervention not reported
Proportion of patients who discontinued treatment due to adverse events (over 6 months trial period) · Patients between three and 10 years old with a diagnosis of BECTS
1 finding from 1 review
Intervention not reported
Proportion of patients with an adverse event · Patients between three and 10 years old with a diagnosis of BECTS
The intervention showed no clear difference in proportion of patients with an adverse event (moderate certainty).
1 finding from 1 review
Intervention not reported
Changes in cognitive function · Patients between three and 10 years old with a diagnosis of BECTS
1 finding from 1 review
Intervention not reported
Proportion of patients who discontinued treatment due to adverse events (96 weeks trial period) · Patients with a clinical and EEG diagnosis of BECTS
It is very uncertain whether the intervention changes proportion of patients who discontinued treatment due to adverse… (very low certainty).
1 finding from 1 review
Intervention not reported
Proportion of patients who reported adverse events · Patients with a clinical and EEG diagnosis of BECTS
It is very uncertain whether the intervention changes proportion of patients who reported adverse events (very low certainty).
1 finding from 1 review
Intervention not reported
Proportion of patients with a particular or serious adverse event: 1. Vertigo 2. Headache 3. Somnolence 4. Nausea/Vomiting 5. Tremor 6. Fatigue · Patients with a clinical and EEG diagnosis of BECTS
1 finding from 1 review
Intervention not reported
Changes in cognitive function testing from baseline (96 weeks trial period) · Patients with a clinical and EEG diagnosis of BECTS
1 finding from 1 review
no estimate extracted
39 participants
Very low
Intervention not reported
Proportion of patients who are seizure free at 3 months · Patients between three and 12 years old with clinical and EEG diagnosis of BECTS
It is very uncertain whether the intervention changes proportion of patients who are seizure free at 3 months (very low certainty).
1 finding from 1 review
Intervention not reported
Proportion of patients who are seizure free at 12 months · Patients between three and 12 years old with clinical and EEG diagnosis of BECTS
It is very uncertain whether the intervention changes proportion of patients who are seizure free at 12 months (very low certainty).
1 finding from 1 review
Intervention not reported
Proportion of patients who discontinued treatment due to adverse events ( · Patients between three and 12 years old with clinical and EEG diagnosis of BECTS
The intervention showed no clear difference in proportion of patients who discontinued treatment due to adverse… (low certainty).
1 finding from 1 review
Intervention not reported
Low Hb deferral ‐ at first donation visit after commencement of treatment · patients with iron deficiency and/or anaemia in blood donors
The intervention probably leads to lower low Hb deferral ‐ at first donation visit after commencement of… (moderate certainty).
1 finding from 1 review
Intervention not reported
Low Hb deferral ‐ after multiple donation visits · patients with iron deficiency and/or anaemia in blood donors
The intervention probably leads to lower low Hb deferral ‐ after multiple donation visits (moderate certainty).
1 finding from 1 review